Mechanisms and monitoring of bypassing agent therapy
- 1 August 2012
- journal article
- review article
- Published by Elsevier in Journal of Thrombosis and Haemostasis
- Vol. 10 (8), 1478-1485
- https://doi.org/10.1111/j.1538-7836.2012.04793.x
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Joint outcomes in patients with haemophilia: the importance of adherence to preventive regimensHaemophilia, 2009
- Differential response to bypassing agents complicates treatment in patients with haemophilia and inhibitorsHaemophilia, 2009
- Tissue factor around dermal vessels has bound factor VII in the absence of injuryJournal of Thrombosis and Haemostasis, 2007
- Individualization of bypassing agent treatment for haemophilic patients with inhibitors utilizing thromboelastographyHaemophilia, 2006
- Inhibitor Development in Hemophiliacs: The Roles of Genetic versus Environmental FactorsSeminars in Thrombosis and Hemostasis, 2006
- A Cell-Based Model of Thrombin GenerationSeminars in Thrombosis and Hemostasis, 2006
- High dose factor VIIa improves clot structure and stability in a model of haemophilia BBritish Journal of Haematology, 2005
- Major surgery in a severe haemophilia A patient with high titre inhibitor: use of the thrombin generation test in the therapeutic decisionHaemophilia, 2005
- Thromboelastography and recombinant factor VIIa—hemophilia and beyondSeminars in Hematology, 2004
- Recombinant Factor VIIa: The Possibilities for MonitoringTransfusion Alternatives in Transfusion Medicine, 2003